Germany’s effort to turn more university research into high-growth technology companies has entered a decisive phase. A year ago, the federal government selected ten “Startup Factories” under the EXIST lighthouse competition, involving 126 universities and research institutions and 144 business and financing partners. Private partners have pledged around €110 million.
Each factory can receive up to €10 million in federal funding over five years, matched by private partners. The goal is to produce more viable science-based spin-offs and shorten the path from laboratory research to commercial scale.
For Europe, the programme is a useful test case. Can a country with strong research, an established industrial base and a historically fragmented venture market build the conditions for globally competitive DeepTech companies?
The ten factories span regions with very different industrial and research profiles. Göttingen, Hannover and Braunschweig have strengths in life sciences; Aachen and Cologne in engineering and business; Rhine-Main in science, industry and finance.
Hamburg brings logistics and trade expertise, the Ruhr a dense industrial and university base, while Northern Bavaria, Baden-Württemberg and Central Germany are major manufacturing and research regions. Berlin-Brandenburg adds a more internationally connected technology ecosystem, and the southwest has strong cross-border links.
The broader point is that DeepTech ecosystems tend to form around existing concentrations of research, industrial demand, specialist talent and capital.
The debate about DeepTech is often framed as a future risk. In several key technology fields, the race is already well under way. In AI, quantum computing and robotics, Europe is competing primarily with the United States and China. Germany’s high-tech Agenda reflects the political importance now attached to these fields.
Germany’s challenge is therefore larger than technology transfer alone. The country has strong research, experienced industrial companies, a substantial SME base and deep engineering expertise. What remains weaker is the mechanism for converting these assets into companies that can commercialise quickly, attract capital and scale internationally.
This is also a wider European problem. Research strength and industrial capability do not automatically translate into entrepreneurial outcomes. The links between universities, founders, corporates and investors remain uneven, particularly outside the largest technology hubs.
Germany’s traditional economic model is under pressure. According to an EY analysis, the country’s industrial sector shed roughly 124,000 jobs in 2025 alone. At the same time, an estimated 522,000 people worked in German startups and scale-ups in 2024.
That contrast captures a central economic question: how quickly can Germany turn scientific strength, industrial depth and engineering talent into the companies and jobs of the next decade?
New venture creation will not replace industrial employment one-for-one. But the ability to build new technology companies matters increasingly for productivity, investment and the renewal of industrial supply chains.
Stronger links between universities, founders, industry and investors are part of that shift, but the wider regulatory and financing environment remains decisive. Slow permitting, cautious capital and risk-averse hiring practices can constrain growth regardless of the quality of individual programmes.
For DeepTech companies, pitch events and mentoring are rarely enough. Many require test sites, laboratory access, technical validation, data, certification pathways and first reference customers before they can demonstrate commercial viability.
This is where Germany’s industrial base matters. Regions with concentrations of manufacturing, energy, chemicals or logistics companies can provide access to real operating environments where technologies are tested, refined and evaluated alongside potential customers.
Industrial validation reduces both technical and commercial uncertainty. A pilot can show whether a technology works outside the laboratory, whether customers are prepared to integrate it, and whether a founding team can operate within complex industrial organisations.
For investors, these signals often matter more than early market estimates. The sectoral challenge is to make access to industrial validation systematic rather than dependent on chance or personal networks.
DeepTech financing remains one of Europe’s structural weaknesses. A 2026 industry report puts Europe’s annual DeepTech funding shortfall at €3.43 to 20.59 billion ($4 to $24 billion), with much of the gap concentrated at the growth stage.
The problem begins earlier. Research-based companies often require substantial capital before they have a finished product, meaningful revenue or even a fully formed commercial organisation. Development cycles are longer than in many software businesses, while technical risk remains high for longer.
This creates the familiar “Valley of Death” between scientific proof and an investable company. Teams may have strong intellectual property and validated research but lack the capital required for prototyping, certification, manufacturing preparation or customer trials.
Public funding can absorb some early risk, but it cannot substitute for a functioning private capital market. The harder question is whether companies can secure enough follow-on capital to remain in Europe through industrialisation and international expansion.
Twelve months in, the visible parts of the programme are largely in place. The more important questions now are about commercial outcomes.
Which teams reach paying customers? Which pilots become contracts? Which companies attract substantial follow-on capital? Which regions can attract specialist talent from abroad? And which companies can scale from Europe without eventually relocating headquarters, intellectual property or core operations elsewhere?
Those are the measures that matter beyond the Startup Factories themselves. They will show whether Germany is improving the underlying conditions for science-based company building or simply adding another layer to an already complex innovation system.
The central issue is whether Europe can create a more reliable path from research to industrial validation, private capital and global scale. Germany’s experience is useful because it shows, in practical terms, where that path remains weak.
Source: EU-Startups
